The cytochrome P450IA1 (IA1) gene product, aryl hydrocarbon hydroxylase, has been most closely associated with the metabolic activation of polycyclic aromatic hydrocarbon (PAH) procarcinogens and protoxins to their ultimate pathological form. Many of these PAH are found prevalently in our environment. Although, normally transcriptionally inactive, the IA1 gene is known to be induced when organisms are exposed to many of these same compounds. A large variation in the expression of the IA1 gene has been demonstrated in the human population. Our laboratory has been involved in experiments to elucidate mechanisms controlling the expression of this gene. Studies completed during the first two years of this proposal have established the involvement of four distinct cis-regulatory elements in the expression of the human IA1 gene, i.e. a proximal and a distal positive acting xenobiotic- responsive element (XRE), a glucocorticoid-responsive element that acts synergistically with the two XREs, and a negative regulatory element (NRE). Although several groups have described specific trans-regulatory proteins and DNA binding sites involved in the positive regulation of the IA1 gene, very little is understood about the negative regulatory components. This proposal is designed to further characterize the NRE and to extend these studies to the isolation and characterization of the postulated trans negative regulatory factor (NRF) whose action is mediated by these sequences. First, experiments will be conducted to determine the orientation-, position-, enhancer-, and promoter-dependence of the NRE. The tissue- and species-specificity of the NRE, if any, will also be examined. Second, the specific interaction of trans- acting proteins with the NRE will be analyzed. Third, the effect of specific mutations on the identified protein binding sites will be determined. Fourth, we will purify and characterize the trans- acting NRF. Finally, a cDNA clone for the NRF will be isolated, characterized, and employed to examine the expression of the NRF and obtain an initial estimate of its genetic complexity. These studies will add greatly to our understanding of the mechanisms controlling the activity of the IA1 enzyme and will also contribute to our knowledge of eucaryotic gene regulation in general.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES003832-06
Application #
3251564
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1985-12-06
Project End
1991-11-30
Budget Start
1989-12-01
Budget End
1990-11-30
Support Year
6
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
Schools of Medicine
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Poch, Mark T; Al-Kassim, Loola; Smolinski, Steven M et al. (2004) Two distinct classes of CCAAT box elements that bind nuclear factor-Y/alpha-actinin-4: potential role in human CYP1A1 regulation. Toxicol Appl Pharmacol 199:239-50
Linder, M W; Falkner, K C; Srinivasan, G et al. (1999) Role of canonical glucocorticoid responsive elements in modulating expression of genes regulated by the arylhydrocarbon receptor. Drug Metab Rev 31:247-71
Piechocki, M P; Hines, R N (1998) Functional characterization of the human CYP1A1 negative regulatory element: modulation of Ah receptor mediated transcriptional activity. Carcinogenesis 19:771-80
Boucher, P D; Piechocki, M P; Hines, R N (1995) Partial characterization of the human CYP1A1 negatively acting transcription factor and mutational analysis of its cognate DNA recognition sequence. Mol Cell Biol 15:5144-51
Boucher, P D; Hines, R N (1995) In vitro binding and functional studies comparing the human CYP1A1 negative regulatory element with the orthologous sequences from rodent genes. Carcinogenesis 16:383-92
Piechocki, M P; Hines, R N (1994) Oligonucleotide design and optimized protocol for site-directed mutagenesis. Biotechniques 16:702-7
Thomsen, J S; Wang, X; Hines, R N et al. (1994) Restoration of aryl hydrocarbon (Ah) responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor. Carcinogenesis 15:933-7
Boucher, P D; Ruch, R J; Hines, R N (1993) Specific nuclear protein binding to a negative regulatory element on the human CYP1A1 gene. J Biol Chem 268:17384-91
Thomsen, J S; Nissen, L; Stacey, S N et al. (1991) Differences in 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible CYP1A1 expression in human breast carcinoma cell lines involve altered trans-acting factors. Eur J Biochem 197:577-82
Hines, R N; Mathis, J M; Jacob, C S (1988) Identification of multiple regulatory elements on the human cytochrome P450IA1 gene. Carcinogenesis 9:1599-605

Showing the most recent 10 out of 11 publications